AHA 2017 | Video: COMPASS: Costs Impact Rivaroxaban Plus Aspirin vs. Aspirin
Drs. Peter Block and Andre Lamy discuss COMPASS which focused on the impact of rivaroxaban plus aspirin vs. aspirin-alone.
Clinical Topics: Anticoagulation Management
Keywords: AHA Annual Scientific Sessions, AHA17, Aspirin, Costs and Cost Analysis, Platelet Aggregation Inhibitors, Factor Xa Inhibitors
< Back to Listings